advanced biologics (abc) focus is to develop innovative and clinically relevant biologic solutions across a wide degree of medical specialties. our company is fully dedicated to improving patients' lives and the health care provider's experience with our products. abc’s award-winning osteoamp® allogeneic-derived growth factor has shown to provide a true alternative to rhbmp-2 with clinical results showcasing faster, safer and denser bone growth. other technologies to follow have included proteios growth factor and osseogen cellular bone matrix. as of 2015, abc established a spin-off, biologica technologies, to focus on the sales, marketing and clinical research for abc's products. www.biologicatechnologies.com